Dow Up1.30% Nasdaq Up0.37%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.62 Up 0.01(0.38%) Oct 30, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 47   51   53  
Cost of Revenue -   -   -  
Gross Profit 47   51   53  
Operating Expenses
Research Development10,475  13,673  17,969  
Selling General and Administrative7,741  6,279  7,939  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (18,169) (19,901) (25,855)
Income from Continuing Operations
Total Other Income/Expenses Net(57)661  2,079  
Earnings Before Interest And Taxes(18,226)(19,240)(23,776)
Interest Expense -   -   -  
Income Before Tax(18,226)(19,240)(23,776)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(18,226)(19,240)(23,776)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (18,226) (19,240) (23,776)
Preferred Stock And Other Adjustments(2,866)(3,210)(4,548)
Net Income Applicable To Common Shares (21,092) (22,450) (28,324)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.